BTK inhibition enhances immunovirotherapy in glioblastoma via tertiary lymphoid structure modulation.

Saved in:
Bibliographic Details
Title: BTK inhibition enhances immunovirotherapy in glioblastoma via tertiary lymphoid structure modulation.
Authors: Kyritsi K; Department of Pathology, Georgia Cancer Center at Augusta University., Zhu D; Department of Cell Biology & Anatomy, Georgia Cancer Center at Augusta University., Ding H; Department of Biostatistics, Data Science and Epidemiology, Augusta University., Friedman GK; Department of Pediatrics, The University of Texas MD Anderson Cancer Center., Lv D; Department of Cell Biology & Anatomy, Georgia Cancer Center at Augusta University., Wang M; Department of Cell Biology & Anatomy, Georgia Cancer Center at Augusta University., Mivechi NF; Department of Radiation Oncology, Georgia Cancer Center at Augusta University., Kollhe R; Department of Pathology, Georgia Cancer Center at Augusta University., Johnson TS; Department of Pediatrics, Pediatric Immunotherapy Program, Georgia Cancer Center at Augusta University., Kaur B; Department of Neurosurgery, Louisiana State University Health Science Center New Orleans., Munn DH; Department of Pediatrics, Pediatric Immunotherapy Program, Georgia Cancer Center at Augusta University., Hong B; Department of Pathology, Georgia Cancer Center at Augusta University.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.64898/2026.06.01.729275